Reduced positive affect (anhedonia) is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: Results from the RESEARCH registry

European Journal of Preventive Cardiology

Volumn 20, Issue 1, 2013, Pages 127-134

  Damen, Nikki L ^a   Pelle, Aline J ^a   Boersma, Eric ^b   Serruys, Patrick W ^b   Van Domburg, Ron T ^b   Pedersen, Susanne S ^a,b  

^a TILBURG UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

All cause mortality; anhedonia; coronary artery disease; percutaneous coronary intervention

Indexed keywords

RAPAMYCIN;

ADULT; ANHEDONIA; ARTICLE; CAUSE OF DEATH; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANHEDONIA; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; REGISTRIES; RISK FACTORS;

EID: 84873884916     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/2047487312436452     Document Type: Article

References (39)

1. Januzzi JL, Stern TA, Pasternak RC, et al. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med. 2000 ; 160 (13). 1913-1921
2. Astin F, Jones K, Thompson DR. Prevalence and patterns of anxiety and depression in patients undergoing elective percutaneous transluminal coronary angioplasty. Heart Lung. 2005 ; 34 (6). 393-401
3. Strik JJMH, Denollet J, Lousberg R, et al. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol. 2003 ; 42 (10). 1801-1807
4. Denollet J, Pedersen SS, Daemen J, et al. Reduced positive affect (anhedonia) predicts major clinical events following implantation of coronary-artery stents. J Intern Med. 2008 ; 263 (2). 203-211
5. Brummett BH, Boyle SH, Siegler IC, et al. Ratings of positive and depressive emotion as predictors of mortality in coronary patients. Int J Cardiol. 2005 ; 100 (2). 213-216
6. Pressman SD, Cohen S. Does positive affect influence health?. Psychol Bull. 2005 ; 131 (6). 925-971
7. Tellegen A, Watson D, Clark LA. On the dimensional and hierarchical structure of affect. Psychol Sci. 1999 ; 10 (4). 297-303
8. Larsen JT, McGraw AP, Cacioppo JT. Can people feel happy and sad at the same time?. J Pers Soc Psychol. 2001 ; 81 (4). 684-696
9. Middleton R, Byrd K. Psychosocial factors and hospital readmission status of older persons with cardiovascular disease. J Appl Rehabil Counsel. 1996 ; 27 (4). 3-10
10. Smart Richmann L, Kubzansky L, Maselko J, et al. Positive emotion and health: going beyond the negative. Health Psychol. 2005 ; 24 (4). 422-429
11. Rozanski A, Kubzansky LD. Psychologic functioning and physical health: a paradigm of flexibility. Psychosom Med. 2005 ; 67 (Supplement 1). S47 - S53
12. Davidson KW, Mostofsky E, Whang W. Don't worry, be happy: positive affect and reduced 10-year incident coronary heart disease: the Canadian Nova Scotia Health Survey. Eur Heart J. 2010 ; 31 (9). 1065-1070
13. Kubzansky LD, Sparrow D, Vokonas P, et al. Is the glass half empty or half full? A prospective study of optimism and coronary heart disease in the normative aging study. Psychosom Med. 2001 ; 63 (6). 910-916
14. Davidson KW, Burg MM, Kronish IM, et al. Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Arch Gen Psychiatry. 2010 ; 67 (5). 480-488
15. Versteeg H, Pedersen S, Erdman R, et al. Negative and positive affect are independently associated with patient-reported health status following percutaneous coronary intervention. Qual Life Res. 2009 ; 18 (8). 953-960
16. Pelle A, Pedersen S, Erdman R, et al. Anhedonia is associated with poor health status and more somatic and cognitive symptoms in patients with coronary artery disease. Qual Life Res. 2011 ; 20 (5). 643-651
17. Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the 'real world': the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation. 2004 ; 109 (2). 190-195
18. Ong ATL, van Domburg RT, Aoki J, et al. Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol. 2006 ; 47 (7). 1356-1360
19. Pedersen SS, Denollet J, Ong AT, et al. Impaired health status in Type D patients following PCI in the drug-eluting stent era. Int J Cardiol. 2007 ; 114 (3). 358-365
20. Rumsfeld JS, Magid DJ, Plomondon ME, et al. Veterans affairs angina with extremely serious operative mortality investigators. health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia. J Am Coll Cardiol. 2003 ; 41 (10). 1732-1738
21. Goodyear MDE, Krleza-Jeric K, Lemmens T. The Declaration of Helsinki. Br Med J. 2007 ; 335 (7621). 624-625
22. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 ; 67 (6). 361-370
23. Spinhoven P, Ormel J, Sloekers PP, et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997 ; 27 (2). 363-370
24. Martin CR, Lewin RJP, Thompson DR. A confirmatory factor analysis of the Hospital Anxiety and Depression Scale in coronary care patients following acute myocardial infarction. Psychiatry Res. 2003 ; 120 (1). 85-94
25. Emons HM KS and Pedersen SS. Dimensionality of the Hospital Anxiety and Depression Scale (HADS) in cardiac patients: comparison of Mokken Scale Analysis and Factor Analysis. Assessment 2010 [epublication ahead of print].
26. Dunbar M, Ford G, Hunt K, et al. A confirmatory factor analysis of the Hospital Anxiety and Depression scale: comparing empirically and theoretically derived structures. Br J Clin Psychol. 2000 ; 39 (1). 79-94
27. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J. 1986 ; 292 (6516). 344-344
28. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med. 2004 ; 66 (3). 411-421
29. Freedland KE, Babyak MA, McMahon RJ, et al. Statistical guidelines for psychosomatic medicine. Psychosom Med. 2005 ; 67 (2). 167-167
30. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996 ; 49 (12). 1373-1379
31. Steptoe A, O'Donnell K, Badrick E, et al. Neuroendocrine and inflammatory factors associated with positive affect in healthy men and women. Am J Epidemiol. 2008 ; 167 (1). 96-102
32. Berkman LF, Blumenthal J, Burg M, et al. Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. J Am Med Assoc. 2003 ; 289 (23). 3106-3116
33. Frasure-Smith N, Prince R. The ischemic heart disease life stress monitoring program: impact on mortality. Psychosom Med. 1985 ; 47 (5). 431-445
34. Blumenthal JA, Sherwood A, Babyak MA, et al. Effects of Exercise and Stress Management Training on Markers of Cardiovascular Risk in Patients With Ischemic Heart Disease. J Am Med Assoc. 2005 ; 293 (13). 1626-1634
35. Strachowski D, Khaylis A, Conrad A, et al. The effects of cognitive behavior therapy on depression in older patients with cardiovascular risk. Depress Anxiety. 2008 ; 25 (8). E1 - E10
36. Grossman P, Tiefenthaler-Gilmer U, Raysz A, et al. Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in well-being. Psychother Psychosom. 2007 ; 76 (4). 226-233
37. Pedersen SS, Denollet J, van Gestel YR, et al. Clustering of psychosocial risk factors enhances the risk of depressive symptoms 12-months post percutaneous coronary intervention. Eur J Cardiovasc Prev Rehabil. 2008 ; 15 (2). 203-209
38. Rozanski A, Blumenthal JA, Davidson KW, et al. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol. 2005 ; 45 (5). 637-651
39. Pedersen SS, van den Broek KC, Erdman RAM, et al. Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace. 2010 ; 12 (10). 1446-1452